{
  "thread": {
    "uuid": "2cac7c1c320e97b05aba8c0b1b6b7e8a89476720",
    "url": "https://pharma.economictimes.indiatimes.com/news/pharma-industry/small-drug-companies-face-shutdown-threat-amidst-strict-gmp-compliance/121942243",
    "site_full": "pharma.economictimes.indiatimes.com",
    "site": "indiatimes.com",
    "site_section": "https://world.einnews.com/ajax/headlines",
    "site_categories": [
      "top_news_nz",
      "top_news_au",
      "top_news_ae",
      "top_news_us",
      "top_news_gb",
      "top_news_th",
      "top_news_sa",
      "top_news_sg",
      "top_news_ph",
      "top_news_hk",
      "top_news_nl",
      "top_news_qa",
      "top_news_ie",
      "top_news_pk",
      "top_news_id",
      "top_news_dk",
      "top_news_eg",
      "top_news_za",
      "top_news_my",
      "top_news_kw",
      "top_news_be",
      "top_news_in",
      "top_news_ca",
      "top_news_iq",
      "top_news"
    ],
    "section_title": "",
    "site_title": "ET Pharma: Pharma News | Latest Pharma Sector Information and Updates",
    "title": "Pharmaceutical Companies: Small Drug Companies Face Shutdown Threat Amidst Strict GMP Compliance, ETPharma",
    "title_full": "Pharmaceutical Companies: Small Drug Companies Face Shutdown Threat Amidst Strict GMP Compliance, ETPharma",
    "published": "2025-06-19T04:23:00.000+03:00",
    "replies_count": 0,
    "participants_count": 1,
    "site_type": "news",
    "country": "IN",
    "main_image": "https://etimg.etb2bimg.com/thumb/msid-121942243,imgsize-38244,width-1200,height=627,overlay-etpharma,resizemode-75/news/pharma-industry/small-drug-companies-face-shutdown-threat-amidst-strict-gmp-compliance.jpg",
    "performance_score": 0,
    "domain_rank": 294,
    "domain_rank_updated": "2025-06-03T00:00:00.000+03:00",
    "licensing_agency": [],
    "social": {
      "facebook": {
        "likes": 0,
        "comments": 0,
        "shares": 0
      },
      "vk": {
        "shares": 0
      }
    }
  },
  "uuid": "2cac7c1c320e97b05aba8c0b1b6b7e8a89476720",
  "url": "https://pharma.economictimes.indiatimes.com/news/pharma-industry/small-drug-companies-face-shutdown-threat-amidst-strict-gmp-compliance/121942243",
  "ord_in_thread": 0,
  "author": "www.ETPharma.com",
  "published": "2025-06-19T04:23:00.000+03:00",
  "title": "Pharmaceutical Companies: Small Drug Companies Face Shutdown Threat Amidst Strict GMP Compliance, ETPharma",
  "text": "Pharma Industry- 2 min read\nWith no upgradation plan, several small drug companies may shut operations\nSome executives believe that 'stop production notices' will be issued to units not complying with the newly-notified standards, which may inflate drug prices.\nNew Delhi: Thousands of\nOnly a fraction of such units, 1,700 out of an estimated 6,000, have submitted plans for upgradation as per the newly-notified\nIndustry executives said they anticipate many units to shut down and thousands of job losses as these units struggle with high costs needed to make the necessary infrastructure improvements. The government, meanwhile, is likely to initiate site audits and kick-off regulatory action against those not complying with the new standards, the people said.\nExperts noted that if the government takes stringent action, it may cause\n\"Next few months will see a lot of small sector units getting closed, resulting in increased unemployment. The upgradation requirement to Schedule M has created challenges for small and medium units potentially leading to closures and unemployment,\" said an industry executive, raising concerns about the future of these units.\nSome executives believe that 'stop production notices' will be issued to units not complying with the newly-notified standards, which may inflate drug prices. \"These units require hand holding by the government and if they do not get further support, then production will stop, resulting in escalation of drug prices,\" a second executive said.\nHealth ministry officials however stressed that sufficient time has been given to the industry for complying with the new norms.\nEarlier the ministry had received several representations from pharma associations with annual revenues of less than '250 crore for extension of timeline for the implementation of revised Schedule M. Schedule M of the Drugs and Cosmetics Act outlines quality standards for pharma products.\nTo address their concerns, in February, the ministry issued another notification for extension of implementation of revised Schedule M whereby manufacturers with less than Rs 250 crore revenues were required to file an application to the\npharmaceutical companiesin the micro, small and medium enterprise (MSME) sector face the grim prospect of closure, having passed the May-end deadline for submitting plans to the government for upgrading their manufacturing facilities.Only a fraction of such units, 1,700 out of an estimated 6,000, have submitted plans for upgradation as per the newly-notified\nGood Manufacturing Practices(GMP), people in the know told ET.Industry executives said they anticipate many units to shut down and thousands of job losses as these units struggle with high costs needed to make the necessary infrastructure improvements. The government, meanwhile, is likely to initiate site audits and kick-off regulatory action against those not complying with the new standards, the people said.\nExperts noted that if the government takes stringent action, it may cause\ndrug shortagesin areas like cancer, where there are fewer manufacturing units.\"Next few months will see a lot of small sector units getting closed, resulting in increased unemployment. The upgradation requirement to Schedule M has created challenges for small and medium units potentially leading to closures and unemployment,\" said an industry executive, raising concerns about the future of these units.\nSome executives believe that 'stop production notices' will be issued to units not complying with the newly-notified standards, which may inflate drug prices. \"These units require hand holding by the government and if they do not get further support, then production will stop, resulting in escalation of drug prices,\" a second executive said.\nHealth ministry officials however stressed that sufficient time has been given to the industry for complying with the new norms.\nEarlier the ministry had received several representations from pharma associations with annual revenues of less than '250 crore for extension of timeline for the implementation of revised Schedule M. Schedule M of the Drugs and Cosmetics Act outlines quality standards for pharma products.\nTo address their concerns, in February, the ministry issued another notification for extension of implementation of revised Schedule M whereby manufacturers with less than Rs 250 crore revenues were required to file an application to the",
  "highlightText": "",
  "highlightTitle": "",
  "highlightThreadTitle": "",
  "language": "english",
  "sentiment": "negative",
  "categories": [
    "Economy, Business and Finance",
    "Social Issue",
    "Health"
  ],
  "topics": [
    "Economy, Business and Finance->financial and economic news",
    "Economy, Business and Finance->business governance",
    "Economy, Business and Finance->healthcare industry",
    "Social Issue->social problem",
    "Social Issue->fraternal and community group",
    "Health->drug rehabilitation",
    "Health->health care approach",
    "Health->health organisation"
  ],
  "ai_allow": true,
  "has_canonical": false,
  "breaking": null,
  "webz_reporter": false,
  "external_links": [],
  "entities": {
    "persons": [],
    "locations": [],
    "organizations": []
  },
  "syndication": {
    "syndicated": false,
    "syndicate_id": null,
    "first_syndicated": false
  },
  "trust": {
    "categories": [],
    "top_news": [
      "top_news_nz",
      "top_news_au",
      "top_news_ae",
      "top_news_us",
      "top_news_gb",
      "top_news_th",
      "top_news_sa",
      "top_news_sg",
      "top_news_ph",
      "top_news_hk",
      "top_news_nl",
      "top_news_qa",
      "top_news_ie",
      "top_news_pk",
      "top_news_id",
      "top_news_dk",
      "top_news_eg",
      "top_news_za",
      "top_news_my",
      "top_news_kw",
      "top_news_be",
      "top_news_in",
      "top_news_ca",
      "top_news_iq",
      "top_news"
    ],
    "bias": "center"
  },
  "rating": null,
  "crawled": "2025-06-19T07:43:51.102+03:00",
  "updated": "2025-06-19T04:46:23.000+00:00"
}